ACR statement on CMS Medicare Advantage final rule

(American College of Rheumatology) In August 2018, the CMS announced that Medicare Advantage (MA) plans would be allowed to utilize step therapy for Part B drugs. The American College of Rheumatology (ACR) expressed strong concerns about this proposal. The rheumatology community received some good news in this week's final rule from CMS, which makes changes to the original proposal and addresses several of the community's recommendations.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news